Literature DB >> 19813064

Succinylcholine and morbid obesity: the debate continues...

Jay B Brodsky, Harry J M Lemmens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19813064     DOI： 10.1007/s11695-009-9992-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  5 in total

1.  Rapacuronium: why did it fail as a replacement for succinylcholine?

Authors:  P F White
Journal:  Br J Anaesth       Date:  2002-02       Impact factor: 9.166

2.  Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia.

Authors:  K C McCourt; L Salmela; R K Mirakhur; M Carroll; M T Mäkinen; M Kansanaho; C Kerr; G J Roest; K T Olkkola
Journal:  Anaesthesia       Date:  1998-09       Impact factor: 6.955

3.  The dose of succinylcholine in morbid obesity.

Authors:  Harry J M Lemmens; Jay B Brodsky
Journal:  Anesth Analg       Date:  2006-02       Impact factor: 5.108

Review 4.  Rocuronium versus succinylcholine for rapid sequence induction intubation.

Authors:  Jeffrey J Perry; Jacques S Lee; Victoria A H Sillberg; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 5.  Goodbye suxamethonium!

Authors:  C Lee
Journal:  Anaesthesia       Date:  2009-03       Impact factor: 6.955
  5 in total
  1 in total

1.  Succinylcholine in morbidly obese patients: another interesting advantage.

Authors:  Michele Carron; Ulderico Freo; Carlo Ori
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.